Central nervous system involvement in systemic lupus erythematosus: Cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations

Lupus

Volumn 9, Issue 8, 2000, Pages 573-583

  Sanna, G ^a   Piga, M ^a   Terryberry, J W ^a   Peltz, M T ^a   Giagheddu, S ^a   Satta, L ^a   Ahmed, A ^a   Cauli, A ^a   Montaldo, C ^a   Passiu, G ^a   Peter, J B ^a   Shoenfeld, Y ^a   Mathieu, A ^a  

^a Ctro per le Malat Reumatiche Sist   (Italy)

Author keywords

Autoantibodies; Central nervous system; MRI; SPECT; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; SERINE PROTEINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEROLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0033772356     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300678828695     Document Type: Article

References (78)

1. Central nervous system lupus erythematosus: The need for classification
2. Controversies in lupus: Nervous system involvement
3. Central nervous system lupus erythematosus: The value of magnetic resonance imaging
4. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus
5. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers
6. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus
7. Abnormalities of magnetic resonance imaging of the central nervous system in patients with systemic lupus erythematosus correlate with disease severity
8. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropyschiatric lupus erythematosus
9. Cerebral lesions in systemic lupus erithematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody
10. Magnetic resonance imaging of the brain in systemic lupus erythematosus
11. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease
12. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus
13. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus
14. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement
15. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations
16. Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events
17. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography
18. Single photon emission computed tomography scanning in childhood systemic lupus erythematosus
19. Regional cerebral blood flow in juvenile systemic lupus erythematosus: A prospective SPECT study
20. Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955-1977
21. Cerebrospinal fluid and the choroid plexus during acute immune complex disease
22. Neurofilament antibodies in systemic lupus erythematosus
23. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus
24. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers
25. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus like disease, and the primary antiphospholipid syndrome
26. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies
27. Nervous system lupus: Pathogenesis and rationale for therapy
28. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease
29. A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus
30. Identification and cloning of a brain autoantigen in neuro-behavioral SLE
31. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus
32. Correlation of autoantibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus
33. Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus
34. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests
35. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations
36. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody
37. Anti-ribosomal and 'P-peptide'-specific autoantibodies bind to T lymphocytes
38. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus
39. Antineuronal antibodies in systemic lupus erythematosus
40. Brain-reactive lymphocytotoxic antibody in the cerebrospinal fluid of patients with systemic lupus erythematosus: Correlation with central nervous system involvement
41. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus
42. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging
43. Antibodies to tubulin and microtubule-associated proteins. A study in diabetes mellitus, systemic lupus erythematosus and rheumatoid arthritis
44. Lupus anticoagulant in children with thrombosis
45. Cerebral lupus vasculopathy. Mechanisms and clinical relevance
46. The 1982 revised criteria for the classification of systemic lupus erythematosus
47. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
48. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus
49. 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician
50. Clinical features of SLE
51. Neuronal antibodies and cognitive function in systemic lupus erythematosus
52. Prevalence of cognitive impairment in systemic lupus erythematosus
53. Myelin- and microbe-specific antibodies in Guillain-Barre syndrome
54. Autoantibodies in neurodegeneration: Frequencies and intrathecal analysis
55. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations
56. Threshold analysis using diagnostic tests with multiple results
57. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning
58. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus
59. MRI and SPECT investigations of the CNS in SLE patients
60. Neurochemistry of brain lesions determined by spectroscopy imaging in systemic lupus erythematosus
61. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations
62. Prevalence of 13 autoantibodies and of 16/6 and related pathogenic idiotypes in 465 patients with systemic lupus erythematosus and their relationship with disease activity
63. Comparison of natural autoantibodies to autoantibodies arising during lupus in (NZB x NZW) F1 mice
64. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals
65. Sera with high levels of anti-smooth muscle and anti-mitochondrial antibodies frequently bind to cytoskeleton proteins
66. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients
67. An idiotype D23-bearing polyspecific murine anti-DNA monoclonal antibody forms glomerular immune deposits. Pathogenic role of natural autoantibodies?
68. Lactosylsphingosine-reactive antibody and CEA in patients with colorectal cancer
69. Antibodies against gangliosides in patients with SLE and neurological manifestations
70. Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy
71. Antiglycolipid antibodies in normal and pathologic human sera and synovial fluids
72. Antiganglioside antibodies in cerebro-spinal fluid of children with neuropsychiatric lupus erythematosus
73. Immune-mediated oligodendrocyte injury
74. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum
75. Fc receptors for IgG on cultured human microglia mediated cytotoxicity and phagocytosis of antibody-coated targets
76. Oligoclonal banding of IgG in CSF blood-brain barrier function and MRI findings in patients with sarcoidosis systemic lupus, erythematosus and Bechet's disease involving the nervous system
77. Identification and characterization of an anti-glial acidic fibrillary protein antibody with a uniquespecificity in a demented patient with an autoimmune disorder
78. Circulating autoantibodies to neuronal and glial filament proteins in autism